Phase I–IV Clinical Trials
Phase I–IV Clinical Trials
Comprehensive Clinical Development Under One Roof
As a fully integrated hybrid organization, Triumpharma provides seamless continuity from early-phase discovery to late-stage clinical development. Our specialized “One-Stop-Shop” infrastructure allows us to expertly manage Phase I through Phase IV trials for both small and large molecules, eliminating the complexity of coordinating multiple vendors.
From navigating the unique challenges of rare diseases and controlled substances to complex biologic therapies, our integrated team ensures your trials are executed with the highest ethical standards, uncompromising quality, and strict adherence to GCP guidelines.
Specific Phase I Expertise & Deliverables:
- First-in-Human and Proof of Concept (POC) study execution
- Tolerability and pharmacokinetics (escalating single & repeated doses)
- Pharmacodynamics evaluations (single & repeated doses)
- Relative and absolute bioavailability assessments
- Comprehensive Food effect and Drug-Drug Interaction (DDI) studies
